Waled Bahaj
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 23
- Acute Myeloid Leukemia Research 19
- Chronic Myeloid Leukemia Treatments 4
- Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Carmelo Gurnari (24 shared papers)Jaroslaw P. Maciejewski (23 shared papers)Ashiq Masood (3 shared papers)Valeria Visconte (22 shared papers)Tariq Kewan (22 shared papers)Omar Abughanimeh (6 shared papers)Janakiraman Subramanian (2 shared papers)Timothy Pluard (2 shared papers)
- Journals
- Blood (15 papers)Cancers (3 papers)Leukemia (2 papers)Journal of Clinical Oncology (1 paper)Journal of Hematology & Oncology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Waled Bahaj
34 papers receiving 212 citations
Peers
Comparison fields: 5 of 41
- Hematology 88
- Genetics 44
- Cancer Research 58
- Pathology and Forensic Medicine 32
- Oncology 49
Countries citing papers authored by Waled Bahaj
This map shows the geographic impact of Waled Bahaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waled Bahaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waled Bahaj more than expected).
Fields of papers citing papers by Waled Bahaj
This network shows the impact of papers produced by Waled Bahaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waled Bahaj. The network helps show where Waled Bahaj may publish in the future.
Co-authors
The 25 scholars most cited alongside Waled Bahaj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 42 | |
| 2 | 2023 | 19 | |
| 3 | 2018 | 19 | |
| 4 | 2023 | 16 | |
| 5 | 2021 | 15 | |
| 6 | 2022 | 13 | |
| 7 | 2018 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 9 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 5 | |
| 12 | 2017 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2024 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2019 | 2 |
About Waled Bahaj
Waled Bahaj is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Cancer Research, having authored 37 papers that have together received 213 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Protein Degradation and Inhibitors (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (88 citations), Genetics (44 citations), Cancer Research (58 citations), Pathology and Forensic Medicine (32 citations) and Oncology (49 citations). Waled Bahaj has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Carmelo Gurnari, Jaroslaw P. Maciejewski, Ashiq Masood, Valeria Visconte, Tariq Kewan, Omar Abughanimeh, Janakiraman Subramanian, Timothy Pluard, Sam G. Pappas and Arda Durmaz. Their work appears in journals such as Blood, Cancers, Leukemia, Journal of Clinical Oncology and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.